Alabama Metropolitan AL

Lilly's EloraTZP tops Zepbound in mid-stage obesity trial

The Birmingham Star

Oct 4, 2026

INDIANAPOLIS, Indiana: Eli Lilly's experimental combination obesity treatment helped patients with diabetes lose substantially more weight than its blockbuster Zepbound in a head-t…

Read the full story at The Birmingham Star

Lilly's EloraTZP tops Zepbound in mid-stage obesity trial

More from Alabama Metropolitan

Fire damages 12 units at Hoover apartments

Alabama falls 26-10 to Tennessee inside Neyland Stadium (Video)

Alabama stays rain-free all week as fall warmth builds with low humidity and clear skies

68-year-old man dies after being hit by vehicle while crossing Skyland Boulevard

Keelon Russell, Bray Hubbard react to 26-10 loss at Tennessee (Video)

A cool and sunny Sunday in central Alabama (Video)

Kalen DeBoer discusses 26-10 loss at Tennessee (Video)

Alabama's 7-Day Forecast: Cold October Mornings and Warm Afternoons (Video)